MARKHAM, ONTARIO–(Marketwire – Oct. 15, 2010) – Extendicare Real Estate Investment Trust (“Extendicare REIT” or the “REIT”) (TSX:EXE.UN) today announced that it has declared a cash distribution of C$0.07 per unit of the REIT (the “REIT Units”) for the month of October 2010, which is payable to unitholders of record at the close of business on October 29, 2010, and will be paid on November 15, 2010.

Extendicare Limited Partnership (the “Partnership”) also announced that it has declared a cash distribution of C$0.07 per Class B limited partnership unit (the “Exchangeable LP Units”) for the month of October 2010, which is payable to unitholders of record at the close of business on October 29, 2010, and will be paid on November 15, 2010.

The current annualized distribution rate of the REIT and Partnership is C$0.84 per unit, payable in monthly distributions of C$0.07 per unit. In accordance with the distribution policy of both the REIT and the Partnership, unitholders of record at the close of business on the last business day of each calendar month will be paid a distribution on or about the 15^th day of the following month.

Management estimates that approximately 70% of the 2010 distributions of the REIT and Partnership will be characterized as tax-deferred returns of capital for Canadian residents. To the extent the remaining 30% of distributions of the REIT and Extendicare LP to be made in 2010 are taxed as dividends, those paid to Canadian residents are eligible dividends as per the Income Tax Act (Canada). The REIT is not required to, and does not, calculate its “earnings and profits” pursuant to the United States Internal Revenue Code of 1986, as amended, and therefore no portion of its distributions represent qualified dividend income for U.S. tax purposes.

The REIT has a Distribution Reinvestment Plan, which provides Canadian resident holders of REIT Units and Exchangeable LP Units with the opportunity to increase their respective investments at a 3% discount to the volume weighted average trading price of the REIT Units on the TSX for the five trading days immediately preceding the distribution payment date. A copy of the Plan package is available under the investors section of the REIT’s website.

About Us

Extendicare REIT is a leading North American provider of long-term and short-term senior care services through its network of owned and operated health care centers. We employ 37,800 qualified and experienced individuals dedicated to helping people live better through a commitment to quality service that includes post-acute care, rehabilitative therapies and home health care services. Our 263 senior care centers in North America have capacity for approximately 29,200 residents. Extendicare REIT is a specified investment flow-through trust (SIFT) that has been subject to the SIFT tax since January 1, 2007.

Forward-looking Statements

Information provided by Extendicare REIT from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to the REIT and its subsidiaries, including its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “expect”, “intend”, “anticipate”, “believe”, “estimate”, “project”, “plan” or “objective” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and the REIT assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the REIT to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on the REIT’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare REIT with the securities regulatory authorities, available at www.sedar.com and on the REIT’s website at www.extendicare.com.

IRVINE, CA–(Marketwire – October 14, 2010) – Sun Healthcare Group, Inc. (NASDAQ: SUNH) invites investors to listen to a conference call with Sun’s senior management on Thursday, Oct. 28, 2010, at 10 a.m. Pacific / 1 p.m. Eastern to discuss the Company’s earnings for the third quarter of 2010.

To listen to the conference call, dial (888) 437-9364 and refer to Sun Healthcare Group. A recording of the call will be available from 4 p.m. Eastern on Oct. 28, 2010, until midnight Eastern on Nov. 28, 2010, by calling (888) 203-1112 and using access code 4118106.

About Sun Healthcare Group, Inc.

Sun’s subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary.

In May 2010, Sun announced a plan to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies through a series of internal restructurings (the “Restructuring”), subject to the approval of stockholders and other conditions. In connection with the Restructuring, SHG will own and continue to operate all of Sun’s operating subsidiaries, with stockholders of Sun receiving a pro rata distribution of the stock of SHG (the “Separation”). Substantially all of Sun’s currently-owned real estate assets will be owned by Sabra Health Care REIT, Inc., a subsidiary of Sun (“Sabra”) and, immediately after the Separation, Sun will merge into Sabra. Following this merger, SHG will change its name to Sun Healthcare Group, Inc. The common stock of both companies is expected to trade on the NASDAQ Global Select Market. The Restructuring (including the Separation) is expected to be completed in the fourth quarter of 2010.

PORTSMOUTH, NH–(Marketwire – October 14, 2010) –  NitroSecurity, Inc., the leader in high-performance, content-aware security information and event management solutions (SIEM), today announced that Roswell Park Cancer Institute (RPCI) has selected the company’s integrated NitroView SIEM, log management and database monitoring solutions.

Founded in 1898, RPCI is the nation’s first cancer center, and the only upstate New York facility to hold the National Cancer Institute (NCI) designation of “comprehensive cancer center.” Accommodating approximately 200,000 outpatient visits annually, RPCI is a member of the prestigious National Comprehensive Cancer Network (NCCN). Its computing infrastructure comprises approximately 300 servers, 5,000 PCs and a host of tablets and smartphones.

For any healthcare organization, the security of personal health information (PHI) is of the highest priority. IT leadership at RPCI found that despite the Institute’s comprehensive infrastructure, security event and log information was not as rapidly discoverable and actionable as they desired — that data was often spread across disparate and disconnected systems. To remedy this, RPCI conducted an extensive search for a SIEM solution that would address those issues. The goal was to achieve greater visibility into and across data silos to more effectively and efficiently identify potential risks to PHI security.

“RPCI is a leader in cancer research, and leveraging innovative technology helps us achieve our mission: to understand, prevent and cure cancer,” said Edward Pardo, Senior IT Security Engineer at RPCI.

“e-Healthcare initiatives like electronic health records (EHR) and the relentlessly evolving cyberthreat landscape are accelerating the growth of both data and risk,” said Ken Levine, CEO of NitroSecurity. “Just as in the diagnosis of a patient, the ability to act rapidly based on comprehensive information is critical. That’s why marquee healthcare organizations around the country like RPCI have looked to partner with NitroSecurity more than any other SIEM vendor. We provide them with the greatest ability to secure their network environment and meet the letter of the law, without being distracted from their primary mission of saving lives.”

For more information on NitroView and other NitroSecurity offerings, please visit the company’s Web site at http://www.nitrosecurity.com.

About Roswell Park Cancer Institute
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email [email protected].

About NitroSecurity
NitroSecurity develops high-performance security information and event management (SIEM) solutions that protect critical information and infrastructure. NitroSecurity solutions reduce risk exposure and increase network and information availability by removing the scalability and performance limitations of security information management. Utilizing the industry’s fastest analytical tools, NitroSecurity identifies, correlates and remediates threats in minutes instead of hours, allowing organizations to quickly mitigate risks to their information and infrastructure. NitroSecurity serves more than 500 organizations in the energy, healthcare, education, financial services, government, retail, hospitality and managed services industries. For more information, please visit http://www.nitrosecurity.com.

Click here to see all recent news from this company

SAN DIEGO, CA–(Marketwire – October 14, 2010) –  Southern California is in for a real treat. Pacific Liposculpture, Inc. has officially opened the doors to their new premier lipo clinic in the UTC area. Specializing specifically in minimally invasive liposculpture procedures, Pacific Lipo is the premier practice for San Diegans’ liposuction needs.

No longer a taboo or dangerous surgery, liposculpture procedures are routine and performed to remove unwanted fat with minimal discomfort and little to no downtime. Patients do not have to undergo the dangers of general anesthesia, there are no stitches required and you can go back to work the next day.

FDA approved and safer than standard liposuction, Pacific Lipo provides instant results and fat cells are removed permanently. Pacific Lipo uses the most technologically advanced medical techniques and skilled professionals, having performed over 10,000 procedures — liposculpture is all they do and thus makes them the most experienced and best at what they do. Affordable with prices starting at just $895 per area, and free consultations available 7 days a week. For more information on liposculpture services or Pacific Lipo please contact Rodney Davis, Physician Assistant at (858) 794-LIPO or visit www.pacificlipo.com

Click here to see all recent news from this company

GAITHERSBURG, MD–(Marketwire – October 14, 2010) –  Microlog Corporation (PINKSHEETS: MLOG), a Gaithersburg, Maryland-based technology leader in Integrated Voice Response (IVR) and Computer Telephony Integration (CTI) solutions for the Government, Healthcare and Lotteries has been awarded a contract from Moncrief Army Community Hospital, the main medical center at Ft. Jackson in Columbia, South Carolina, for its Wellness Management Suite™ software application and to increase system capacity of the already installed ServiceFirst™ Contact Center. 

“We look forward to providing Moncrief Army Community Hospital with upgrades to our existing products while also installing one of our newest Microlog products,” said Microlog CEO Richard Meccarielli. “We are confident our Wellness Management Suite™ will promote health and wellness at medical facilities and also enable staff to more efficiently keep up with Healthcare Effectiveness and Information Set (HEDIS) information, which has been a troubling issue for many health centers.”

The Wellness Management Suite™ automatically sorts HEDIS data and develops a call list for each health campaign (Diabetes, Colon Cancer, PAP, Mammogram, etc.) to notify patients of wellness appointments needed. The WMS™ application is then prompted to call patients, their identity is verified, and the patient records responses whether or not they would like to set appointments. Data of those requesting appointments is then sent to hospital staff so that they can more efficiently keep track of each patient’s HEDIS record.

Along with the addition of the Wellness Management Suite™, Microlog upgraded the system hardware for their ServiceFirst™ Contact Center to increase system capacity and allow for greater call flow and less downtime for outside callers. 

About Microlog:

Microlog Corporation designs, implements and services patented software applications that enhance the productivity of the customer contact center experience, as well as providing consultation on a variety of system integration options. The company’s services encompass the migration of e-commerce into the traditional call center environment by Web enablement. Microlog’s award winning products support this Web enablement, as well as supporting all inbound and outbound media, telephone, e-mail, fax, and Web for contact centers.

For further information about Microlog’s products and solutions, please contact Vanessa Meccarielli, Investor Relations, at (202) 746-7776 or by email at [email protected].

Click here to see all recent news from this company

WINNIPEG, MANITOBA–(Marketwire – Oct. 14, 2010) – DiaMedica Inc., (TSX VENTURE:DMA) is pleased to announce positive final results from its previously announced type 1 diabetes study.

The study was designed to observe the potential protective and/or regenerative effects on beta cells (cells from the pancreas that produce insulin) in a widely accepted type 1 diabetes animal model. DiaMedica, in consultation with Dr. Maureen Gannon at Vanderbilt University, has confirmed that DM-99 can increase new beta cells by 1,277% (p<0.01) when administered to diseased animals compared to untreated diseased animals. Beta cell proliferation induced by DM-99 trended to be even greater than replication in non-diseased, untreated control animals.

The increased beta cell proliferation led to physiologically important improvements in the diabetic state. Improvements included the restoration of peak levels of plasma insulin to near normal levels (p<0.05) with positive trends of increase in the levels of both pancreatic and plasma insulin, which led to improved blood glucose clearance in a oral glucose tolerance test with DM-99 treatment. On July 8^th, DiaMedica reported initial results of the study that included a 68% reduction in fasting blood glucose (p<0.05) with DM-99.

“These results are very provocative and would indicate that this compound offers both a level of protection of beta cells in a type 1 diabetes animal model as well as induces their proliferation,” stated Dr. Maureen Gannon, Associate professor of Medicine at Vanderbilt University, Division of Diabetes, Endocrinology and Metabolism. “Having a therapeutic compound that can either protect or proliferate beta cells is a key requirement for finding a cure for type 1 diabetes so that therapies involved in replacing or regenerating these cells can work long-term. DM-99 appears to be able to perform both of these functions.”

“The ability of DM-99 to significantly increase beta cell replication combined with our earlier data showing the ability of DM-99 to protect against a variety of autoimmune attacks may result in a first in class treatment for type I diabetes”, stated Mr. Rick Pauls, President and CEO of DiaMedica. “We are currently developing DM-199, a novel recombinant and humanized form of DM-99 for commercialization.”

About DiaMedica

DiaMedica is a biopharmaceutical company focused on developing drugs with the potential to be broadly applicable in treating large unmet diseases including diabetes, autoimmune disorders and neurological diseases by protecting and proliferating a variety of cells. Two of DiaMedica’s products have demonstrated human efficacy in lowering blood sugar levels in people diagnosed with Type 2 diabetes with an excellent safety profile. DiaMedica is listed on the TSX Venture Exchange under the trading symbol “DMA”.

Caution Regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the “forward-looking statements“). These forward-looking statements relate to, among other things, DiaMedica’s objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Specifically, this press release contains forward-looking statements regarding matters such as, but not limited to, the anticipated use of proceeds from the Offering, management’s assessment of DiaMedica’s future plans, information with respect to the advancement of DiaMedica’s research and development programs, and DiaMedica’s other estimates and expectations. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to our research and development programs, the availability of additional financing, risks and uncertainties relating to the anticipated use of proceeds, changes in debt and equity markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, additional financing requirements and access to capital, unproven markets, the cost and supply of raw materials, management of growth, effects of insurers’ willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters.

Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading “Risk Factors” contained in DiaMedica’s 2009 annual information form. DiaMedica cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on DiaMedica’s forward-looking statements to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions, which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of additional financing for research and development companies, and general business and economic conditions. These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, DiaMedica cannot provide assurance that actual results will be consistent with these forward-looking statements. DiaMedica undertakes no obligation to update or revise any forward-looking statement.

FALLS CHURCH, VA–(Marketwire – October 14, 2010) – Accredited Standards Committee X12 announces the release of a collection of XML schemas supporting the content mandated under the Health Insurance Portability and Accountability Act (HIPAA). The schemas are generated from the same database used to publish the HIPAA mandated ASC X12 Technical Reports.

Over the past several years organizations have created proprietary XML schemas based on the generic ASC X12 standards and associated implementation guides. Some of those schemas are sold as part of vendor applications, some are freely distributed, and many are internal to an organization. None represent official derivatives of the associated ASC X12 work products. All implementers will benefit by replacing these separate, uncoordinated initiatives with standardized XML schemas from the recognized authority. This schema production approach ensures that every structure and all data elements can be represented in an XML document and validated with the schemas.

“ASC X12 TR3 Schemas are the only schemas authorized as derivative products of ASC X12 Technical Reports. They ease content integration into and out of back-end systems while promoting standardized XML for this set of HIPAA mandated transactions,” said Cathy Sheppard, Chair, ASC X12.

ASC X12 TR3 Schemas are licensed for internal use or for redistribution in vendor products. Applicable errata will be incorporated into each ASC X12 TR3 Schema, and a new version made available to purchasers at no additional cost, once the errata is mandated under HIPAA. Each schema package also includes the ASC X12 Technical Report Type 2, Constructing XML Schema Definition Element Names from ASC X12 Metadata.

For more information and to purchase ASC X12 TR3 Schemas, visit ASC X12’s On-Line Store – 005010 HIPAA Implementation Guides.

About ASC X12
ASC X12, chartered by the American National Standards Institute (ANSI) in 1979, develops EDI standards and documents for national and global markets. With more than 315 X12 EDI standards and increasing X12 XML schemas, ASC X12 enhances business processes, reduces costs and expands organizational reach. Members include standards experts from health care, insurance, transportation, finance, government, supply chain and other industries.

HOUSTON, TX–(Marketwire – October 14, 2010) –  Velocity Express today announced that Gerald T. Vento has been named Executive Chairman of the Houston, TX-based national logistics and transportation company.

“Velocity partners with its customers to deliver cost effective solutions. We have a strong balance sheet, better technology, national and regional networks and dedicated employees that strategically position us for success,” said Gerald Vento.

“Vento brings laser focus to the business, and as a Velocity customer, we welcome his addition to the company,” said Gough Grubbs, Senior Vice President, Logistics and Distribution, Stage Stores regarding the announcement.

“Stage Stores relies on Velocity to replenish 786 stores weekly through its national network, and Vento’s involvement this year has contributed to improved quality and consistency across Velocity’s complex network operations,” Grubbs added.

Vento brings years of extensive business growth experience to Velocity Express. Vento founded Telecorp PCS, serving as Chairman and CEO, and grew the wireless start-up venture to become a giant company in the mobile telecom business. Within six years after its launch, Telecorp’s annual revenues grew to more than $1.1 billion, and in 2002, Telecorp was sold to ATT Wireless for $5.7 billion.

“Gerald has an extraordinary talent set to guide Velocity’s strategic direction. We are fortunate to have Vento join Velocity,” said Jose Gordo, Managing Director of ComVest, a majority owner of Velocity Express and a leading private investment firm focused on middle market companies. Since 1988, ComVest has invested more than $2 billion of capital in more than 200 public and private companies.

About ComVest
The ComVest Group is a leading private investment firm focused on providing debt and equity solutions to lower middle-market companies with enterprise values of less than $350 million. With extensive financial resources and a broad network of industry experts, ComVest can offer companies total financial sponsorship, critical strategic support, and business development assistance.

About Stage Stores
Stage Stores, Inc. brings nationally recognized brand name apparel, accessories, cosmetics and footwear for the entire family to small and mid-size towns and communities through 787 stores located in 39 states. The Company operates its stores under the five names of Bealls, Goody’s, Palais Royal, Peebles and Stage. For more information about Stage Stores, visit the Company’s web site at www.stagestoresinc.com.

About Velocity Express
Velocity Express operates more than 80 strategically located warehouses and terminal facilities where customers’ packages are sorted, tracked, routed, and delivered. Velocity Express uses a qualified network of independent, licensed drivers who are aligned with the company’s safety and customer service policies. Privately held, Velocity Express is headquartered in Houston, TX.

Additional information about Velocity Express is available www.velocityexpress.com.

SAN JOSE, CA–(Marketwire – October 14, 2010) –  AmbiCom Holdings, Inc. (OTCBB: ABHI) today announced that it has signed a Letter of Intent with one of the world’s largest home care device manufacturers to develop the WiFi solution for their product lines that include blood pressure monitors and healthcare products for home and professional use. Ambicom expects to start generating revenue from this association by the first quarter of 2011 and also believes that this letter of intent can potentially bring significant revenue opportunities for the Company. Further information and details will be forthcoming later this year.

About AmbiCom

AmbiCom is headquartered in San Jose, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company’s wireless modules and devices are based on the Company’s innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware and is bringing new and innovative products to the wireless medical markets and other sectors. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements including, but not limited to, our ability to maintain our website and associated computer systems, our ability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including those risks set forth in the Company’s Current Report on Form 8-K filed on January 15, 2010, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

JERICHO, NY–(Marketwire – October 14, 2010) – SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (“TRDX” or the “Company”) (PINKSHEETS: TRDX) today announces that it has entered into discussion to acquire the exclusive rights to Eco-tabs, an innovative environmental product (www.eco-tabs.com).

Eco-tabs™ are patent pending, multifunctional tablets engineered to oxygenate wastewater, remove hydrogen sulfide odors, prevent corrosion, and initiate aerobic biological breakdown of organic sludge, including natural oils and grease.

The Company expects discussions to continue advancing towards a transaction in the near term.

Dr. Stahl, CEO of TRDX, commented: “We have a lot a belief in the global sales potential of Eco-tabs. I look forward to completing the next steps with them.”

About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)
SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company’s business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

WASHINGTON, DC–(Marketwire – October 14, 2010) –  Despite the promise of a new era of health care in which medicine has shifted from treating conditions to emphasizing prevention fueled by individualized care, a significant gap remains in realizing its benefits because of outmoded attitudes, protocols and procedures targeted for treating mass populations. Such is the core argument and motivation behind the “Personalized Health Manifesto,” released today to kick off the 2010 Translational Medicine Alliance Forum (TMAF) at the Mandarin Oriental. 

Written by journalist and best-selling author David Ewing Duncan and funded by the Ewing Marion Kauffman Foundation, the manifesto is “an old-fashioned call to arms and action plan for a new age of health care” that takes direct aim at the challenges of integrating and implementing personalized health care in the United States and seeks to accelerate the incorporation of personalized health into the current health care system.

“Making this shift to personalized health is a formidable task that will take many years to accomplish, but having scientists and health care leaders sign on to a comprehensive plan is a powerful place to start,” Duncan said. “Launching a new era of personalized health will not require the creation of a radical new blueprint for change. We can use existing plans and reforms that individuals inside and outside of government have already proposed.”

“The manifesto is a fitting catalyst for conversation about how we can better and more quickly get cures to patients amid the billions being spent on research and drug development,” said Lesa Mitchell, vice president of advancing innovation at the Kauffman Foundation. “It directs us to focus on what we need to treat a patient, what we need to change in policy, what do we need to change in process, and how we need to more broadly share data to get the patient what he or she needs.” 

The manifesto’s “action plan” aims to set a new direction for health care, emphasizing prediction, prevention, individualized care and healthy wellness to ensure that the best medicines make it to the marketplace and optimize patient care. By focusing on the whole human organism, the manifesto challenges the prevailing use of drugs and protocols to target populations and averages rather than individuals. It further outlines the necessary groundwork for speeding up the process of moving from research to new drugs and other products and treatments by introducing more effective models that will ultimately improve health and reduce health care costs.

The manifesto was prepared with input from life science leaders representing medicine, business, government, patients, law and the media. Although the work is solely that of the author, these advisors have endorsed the manifesto, and many of them are convening at the TMAF today. The manifesto organizers hope to acquire the endorsement of at least 500 life science leaders by the end of the year. Anyone who reads the manifesto can add their name to the list of endorsers and leave comments by visiting www.kauffman.org/healthmanifesto.

The full manifesto is available at www.kauffman.org/manifesto.

The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. Through its research and other initiatives, the Kauffman Foundation aims to open young people’s eyes to the possibility of entrepreneurship, promote entrepreneurship education, raise awareness of entrepreneurship-friendly policies, and find alternative pathways for the commercialization of new knowledge and technologies. It also works to prepare students to be innovators, entrepreneurs and skilled workers in the 21st century economy through initiatives designed to improve learning in math, engineering, science and technology. Founded by late entrepreneur and philanthropist Ewing Marion Kauffman, the Foundation is based in Kansas City, Mo. and has approximately $2 billion in assets. For more information, visit www.kauffman.org, and follow the Foundation on www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.

David Ewing Duncan is an award-winning, best-selling author of seven books published in 19 languages; he is a journalist and a television, radio and film producer and correspondent. His most recent book is the bestseller Experimental Man: What one man’s body reveals about his future, your health, and our toxic world. He is Chief Correspondent of public radio’s Biotech Nation and a columnist for Fortune. He is the Director of the Center of Life Science Policy at UC Berkeley. He has been a commentator on NPR’s Morning Edition, and a contributing editor for Wired, Discover and Conde Nast Portfolio. David writes for The New York Times, National Geographic, Harper’s, Atlantic Monthly, the San Francisco Chronicle, and many other publications. He is a former special correspondent and producer for ABC Nightline and a correspondent for NOVA’s ScienceNOW! He has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. He is a graduate of Vassar College and now lives in San Francisco.

The Translational Medicine Alliance Forum, hosted by the Kauffman Foundation, the Council for American Medical Innovation and FasterCures, convenes with the common interest of accelerating translational research to the patient. The Forum brings together leaders from academia, government agencies, and pharmaceutical, biotechnology, and venture industries to work toward developing a deeper understanding of effective models to enable and accelerate the progress of translational medicine. Through focused, dynamic sessions and exclusive networking opportunities, attendees have the opportunity to learn about breakthrough approaches and progress on current best practices in translational medicine collaborations. This Forum will focus on the following topics: regulatory science, lessons from the most experienced translational models, how and why rare disease and pediatric medicine are changing the landscape, transparency and access to data, and reverse engineering translational science starting with the patient.

Click here to see all recent news from this company

MADISON, WI–(Marketwire – October 14, 2010) –  TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it will release its 2010 third quarter results on Thursday, October 28, 2010 at 3:00 p.m. CDT.

TomoTherapy will hold an investment community conference call on Thursday, October 28, 2010 beginning at 4:00 p.m. CDT. Fred Robertson, M.D., CEO, and Thomas Powell, CFO, will review third quarter performance and discuss the company’s strategies. To join the conference call, dial 1-800-638-4817 (international 1-617-614-3943) and enter passcode 19539609. A replay of the conference call will be available one hour after the call ends through 10:59 p.m. CDT on November 4, 2010. To access the replay, dial 1-888-286-8010 (international 1-617-801-6888) and enter passcode 40905886.

For individual investors, a live Webcast of the conference call will be available on the Investor Relations page of TomoTherapy.com. Institutional investors can access the Webcast through a password-protected site www.streetevents.com. An archived Webcast of TomoTherapy’s conference call will be available for two weeks.

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

SAN FRANCISCO, CA–(Marketwire – October 14, 2010) –  Mindjet®, the leading provider of software and web-based applications for visually organizing and managing information and ideas, today announced the successful implementation of MindManager™ version 9 with MedMan, a leading medical management services company based in Boise, Idaho. MedMan was looking for a solution to help get closer alignment on internal operations and access to customer information for its 25 remote working employees so they could drive more strategic business plans for their dispersed medical practice client base. MedMan deployed MindManager to help employees create and organize all vital business documents, such as client rosters, HR documents and new hire information, in MindManager so information is easy to access, update and share. Using MindManager, MedMan is able to better serve its clients by providing in-depth and interactive strategy plans that foster idea generation and increase productivity.

MedMan provides administrative and business assistance and consultation for clinics, physician-owned and private medical practices. With numerous clients across multiple states and a workforce that is spread across the country, the business was difficult to keep on track. MedMan needed an easy-to-use and understand platform for tracking key pieces of information related to its clients and business.

“The methodology behind MedMan’s business is helping our clients prioritize needs and establish operational efficiencies to more effectively manage their medical practices,” said Jim Trounson, President of MedMan. “The beauty of MindManager is that we can easily create an actionable business plan with goals, owners and deadlines and work in real-time with the client to show progress and quickly revise the plan when needed. This allows us to the make decisions quicker and faster, making business better for our clients and MedMan.”

MedMan has also taken advantage of the new features in MindManager version 9 including the enhanced integration with Microsoft Outlook, the resource availability feature and the Gantt Project View to understand when clients have available assets and how MedMan can effectively use those to better a client’s business.

“Resource and project management is something that is essential to the survival of any business, whether providing services to clients or providing healthcare to patients,” said Scott Raskin, CEO of Mindjet. “MedMan’s use of MindManager demonstrates the power of visualizing pieces of information that are critical to everyday business function and we are excited to help MedMan provide a unique and necessary service to medical professionals.”

By using MindManager’s extensive visual environment and its innate ability to organize and manage all forms of data and information, MedMan has created elaborate maps that contain all pieces of relevant information for any client, ranging from current business plans, to action items to client rosters. With MindManager, MedMan has been able to strengthen its relationship with existing clients, acquire new ones and provide all clients the service needed to keep business thriving.

MindManager’s visual information maps start with a central theme, and then add branches with ideas, notes, images, tasks, hyperlinks and attachments. Users can easily import from all types of information sources. MindManager maps are used to capture and organize information, and quickly transform thoughts and ideas into fine-tuned visual representations, documents, compelling presentations and winning strategies. MindManager provides a better way to brainstorm, organize facts, plan projects, and communicate results. Users have access to tight integration with Microsoft Outlook and Office to keep the constant stream of information for a project organized in one easy-to-access location, and a visualization and dashboard tool for SharePoint environments with MindManager Explorer for SharePoint. Collaboration tools, real-time map co-editing and web based document storage with Mindjet Catalyst is also available.

For more information visit: www.Mindjet.com

About MedMan
Founded by Jim Trounson in 1977, MedMan’s business model was based on Jim’s experience with outsourcing management companies that were improving the efficiency of hospitals by centralizing and computerizing many of their management functions. MedMan’s goal is to positively affect healthcare delivery to one million patients per year by 2015, based on a proven ability to provide an elite team of professional practice administrators to physician-driven medical clinics.

About Mindjet
Mindjet provides productivity software that helps business professionals visually organize and act upon ideas, information, and resources to drive productivity, team effectiveness, and business innovation. Mindjet products include industry-leading software and online services centered on information mapping, as well as applications that incorporate Mindjet’s innovative visualization technology to improve the usability of leading business applications, including Microsoft® SharePoint® and Salesforce.com. More than 1.5 million people around the world use Mindjet software to clarify thinking, efficiently analyze information, increase team productivity, and make better-informed decisions.

Used by business professionals in 44 of BusinessWeek‘s® 50 “World’s Most Innovative Companies,” Mindjet solutions dramatically boost productivity and team effectiveness. Surveys across several industries show that Mindjet can increase productivity by up to 25 percent by making meetings, common communications, and project management tasks more efficient and effective. Mindjet products are available for free trial or purchase at www.mindjet.com/products/overview, through salesforce.com AppExchange, and through an extensive partner network at www.mindjet.com/community/partners/overview. Mindjet is headquartered in San Francisco and has offices throughout the U.S., Europe and Asia.

id=”nav_links”>

CHICAGO, IL–(Marketwire – October 13, 2010) –  Ziegler (PINKSHEETS: ZGCO) kicked off its 13^th annual Ziegler Senior Living Finance + Strategy Conference at The Hyatt Regency Resort & Spa in Bonita Springs, Florida on Wednesday, September 29, 2010.

The three-day, invitation-only educational conference attracted over 500 attendees and presented cutting-edge finance and strategic positioning trends and issues in senior living and the senior living capital markets. Tom Paprocki, President and CEO of The Ziegler Companies, welcomed the senior living providers, institutional investors, and other industry professionals and introduced the conference facilitator, Dan Hermann, Senior Managing Director & Head of Ziegler Senior Living Finance.

The Ziegler banking team conducted pre-conference workshops allowing attendees to enhance their knowledge of the senior living sector. Such workshops included “Senior Living Finance 101,” “Financial Risk Management 101,” a legal roundtable and a senior living-focused board development workshop. The Ziegler CFO Workshop Series(SM) provided CFOs a roundtable and networking session. All workshops were well attended and provided a general overview of the vast capabilities Ziegler offers.

The opening general session led by a team of capital markets experts laid the foundation for the conference curriculum. The session was a tightly narrated review of the trends unfolding across the senior living continuum and current capital markets investors’ and lenders’ landscapes. Mr. Hermann and Kathryn Brod, Ziegler’s Senior Vice President-Research, and Mike McDaniel, Ziegler’s Senior Managing Director of Sales & Trading, reviewed key trends; Ron Mintz (Vanguard) and Jim LeBuhn (FitchRatings) provided perspectives from the investor and rating agency, respectively. Each educational session of the conference was introduced, tying each to the trends and setting the context for the conference curriculum that would follow.

An array of breakout sessions was offered to attendees. Some hot topics of the conference included case studies of creative solutions for overcoming housing market challenges; key marketing tools for invigorating occupancy; case studies of providers offering services beyond their boundaries; wellness initiatives; and the impact of healthcare reform on the sector. Sessions also included discussions in trends focusing on repositionings and new campus development. Institutional investor, banking, and architects’ panels were also featured. Educational sessions were offered in areas such as investment policymaking, mergers and acquisitions, and corporate structure. All sessions were lead by industry leaders, key associates from senior living providers and Ziegler team experts.

The conference concluded with a panel discussing senior living today, tomorrow and scenarios of the future. For further information on Ziegler or the conference, please visit our website at www.zieglerseniorlivingfinance.com.

About Ziegler:
The Ziegler Companies, Inc. (PINKSHEETS: ZGCO) together with its affiliates (Ziegler) is a specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion and education finance, as well as corporate finance and FHA/HUD. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler creates tailored financial solutions including bond financing, advisory, private placement, seed capital, M&A, risk and asset management. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

MELVILLE, NY–(Marketwire – October 13, 2010) – FONAR Corporation (NASDAQ: FONR), The Inventor
of MR Scanning™, today announced its financial results for the fiscal
year ending June 30, 2010. Total revenues were $31.8 million for the fiscal
year ended June 30, 2010 as compared to $39.7 million for fiscal 2009. The
net loss for the fiscal year ended June 30, 2010, was $3.0 million, as
compared to a net income of $1.1 million for fiscal 2009. The net loss per
share (basic and diluted) for the fiscal year ended June 30, 2010 was
$0.61, as compared to a net income per share (basic and diluted) of $0.21
for the fiscal year ended June 30, 2009.

Revenues from the management of the UPRIGHT® Multi-Position™ MRI
Centers was at $11.1 million for the year ended June 30, 2010 as compared
to $10.3 million one year earlier.

Revenues from UPRIGHT® MRI service and repair fees increased to $11.1
million for the fiscal year ended June 30, 2010 as compared to $10.5
million one year earlier.

Revenues from product sales of the FONAR UPRIGHT® Multi-Position™ MRI
scanners were $9.1 million in the fiscal year ended June 30, 2010, as
compared to $17.2 million in the fiscal year ended June 30, 2009. On June
30, 2010 there were 143 FONAR UPRIGHT® Multi-Position™ MRI scanners
installed in the United States and around the world.

“Total costs and expenses related to operations decreased 15%, from $40.4
million in the fiscal year ended June 30, 2009, to $34.4 million in the
fiscal year ended June 30, 2010,” said Raymond Damadian, M.D., Chairman and
President of Fonar Corporation. “The Company has taken strenuous steps to
controlling costs while continuing to run its business including producing
the FONAR UPRIGHT® Multi-Position™ MRI scanner. These cost cutting
programs were first begun over two years ago.”

At June 30, 2010, total assets were $21.6 million, total current assets
were $14.7 million, total current liabilities were $24.7 million, total
stockholders’ deficiency was $5.8 million and total long-term liabilities
were $2.7 million. Total cash and marketable securities were $1.3 million.
The backlog for MRI product was $14.9 million.

Dr. Damadian remarked, “FONAR has been faced with an ongoing recession and
uncertainty with regard to reimbursement and health care reform. Perhaps
most significant is the prevention of FONAR customers to obtain credit in
this difficult banking environment. Subsequently, FONAR has had to make a
massive amount of cost cuts. Reductions have been made in many categories
most significantly in research and development (R&D), and selling, general
and administrative (S, G & A) areas. Overall, R&D and S, G & A expenses
were reduced over 15% to $14.4 million for the fiscal year ending June 30,
2010 as compared to $17.0 million during the fiscal year ending at June 30,
2009.”

Dr. Damadian said, “FONAR’s prospects have much improved since our nation’s
financial difficulties last year and our customers’ uncertainties regarding
the Deficit Reduction Act (DRA) have eased. Over the past few years, the
medical evidence continues to grow indicating that the FONAR UPRIGHT®
Multi-Position™ MRI is the best MRI for diagnosing spinal problems such
as low back pain or motor vehicle whiplash injuries of the neck as well as
symptoms in other weight-bearing structures of the human body (e.g. knee,
hip, ankle, foot, shoulder, etc.). So as pent-up demand for MRI scanners
surfaces, we look forward to rising sales.”

Fiscal Year Highlights

Dr. Damadian said, “Many of the 2010 fiscal year highlights included
UPRIGHT® MRI installations, an important journal research paper and
significant increases in the patient scan totals among the 9 UPRIGHT®
Multi-Position™ (STAND-UP® MRI) imaging centers managed by FONAR’s
subsidiary Health Management Corporation of America (HMCA). In fact for
fiscal 2010, the scanning centers are now performing collectively
approximately 300 scans per month at each of the nine centers, a 16%
increase over that of the previous year.”

The July 2010 issue of the medical journal “Brain Injury”
(www.fonar.com/news/072110.htm) published a very significant study of 1200
neck pain patients comparing the FONAR UPRIGHT® Multi-Position™ MRI to
a conventional recumbent MRI and the ability to diagnose whiplash trauma
from a motor vehicle accident. The 1200 neck pain patients were divided
into 4 groups, consisting of 2 control neck pain groups that did not
experience whiplash trauma and 2 neck pain groups that did. The
radiologists who read the study images were blinded as to which images were
the patient images and which were the control images. The patients were
examined in both the upright and recumbent positions. The recumbent MRI
images were obtained in a conventional recumbent MRI and the upright images
were obtained in the FONAR UPRIGHT® MRI. The “Brain Injury” study showed
that the fallen cerebellar tonsils (CTE) caused by motor vehicle whiplash
injuries were being missed 60% of the time where the patient was scanned
recumbent-only in a conventional “lie-down MRI” and not scanned upright.
As a result of this study, the medical evidence indicated that the fallen
cerebellar tonsils of a whiplash injury patient can now be reliably
visualized by using the FONAR UPRIGHT® Multi-Position™ MRI. In fact a
customer who recently purchased the FONAR UPRIGHT® MRI said that ‘From
our point of view, here in Germany, the newly published 1200 patient study
in “Brain Injury” sets a “new standard of care” for whiplash injury
patients.’ (www.fonar.com/news/080310.htm)

During the fiscal year ended June 30, 2010, FONAR added to its world-wide
installed base of FONAR UPRIGHT® Multi-Position™ MRIs. Among them was
an installation at Hospital ZorgSaam Zeeuws-Vlaanderen, Terneuzen, The
Netherlands. This 340-bed hospital performs a significant amount of
orthopedic and spine surgery. In addition, it is one of the biggest
centers in The Netherlands for the treatment of bariatric patients. The
UPRIGHT® MRI was sold by Tecserena GmbH, FONAR’s European distributor
since 2006. At the time of the sale, radiologists at Hospital ZorgSaam
Zeeuws-Vlaanderen said they sought the advanced technology provided by the
FONAR UPRIGHT® Multi-Position™ MRI to increase the diagnostic
precision of the images of weight-bearing anatomy, establishing for their
hospital a new standard of excellence throughout Europe for orthopedic
surgical outcomes.

The year was also a big year for North Carolina installations. Prior to
this year there were no FONAR UPRIGHT® Multi-Position™ MRIs in the
state. This year UPRIGHT® MRIs were installed in Charlotte and Durham.
Introducing the FONAR UPRIGHT® Multi-Position™ MRI in North Carolina
was a lengthy process as that state has certificate of need laws designed
to limit the number of advanced medical equipment units entering the state.

Pocatella, Idaho, Las Vegas, Nevada, and Duluth, Minnesota were also
recipients of the UPRIGHT® MRI scanner. For Minnesota, this is the third
scanner purchased by the Center for Diagnostic Imaging (CDI), one of the
nation’s premier diagnostic center businesses. In addition, as the fiscal
year ended, installation of the first UPRIGHT® MRI scanner in Africa was
nearing completion.

Dr. Damadian said, “We are delighted with the results of our efforts on
‘selling scans’ at the nine UPRIGHT® Multi-Position™ MRI, aka
STAND-UP® MRI, managed sites. Currently, the Company manages nine
STAND-UP® MRIs and an earlier model FONAR QUAD™ MRI through its
wholly-owned subsidiary, HMCA (Health Management Corporation of America;
www.hmca.com). The centers’ performance improved steadily monthly. In fact,
the nine STAND-UP® MRIs performed a record 3,183 scans during the month
of March, 2010, an average of 354 per scanner. This is a 35% increase as
compared to 2,354 scans done during the month of March 2009, one year
earlier.”

“We are delighted with the response of referring physicians to the
STAND-UP® MRI. It is becoming increasingly obvious to referring
physicians that scanning patients without the force of gravity, which is
the case with all single-position, recumbent-only MRI scanners, results in
missed, critical pathology,” said Dr. Damadian. “These physicians are now
referring their patients to the scanner and experiencing more accurate
diagnoses and better outcomes for their patients as a result of scanning
them upright and fully weight-bearing in the exact position that generates
their symptoms, which the FONAR UPRIGHT® Multi-Position™ MRI makes
possible. Additionally, patients themselves appreciate the spacious,
non-claustrophobic process of being seated comfortably while watching
television throughout their scan. Mothers can enter the scanner with their
infant on their laps. The infant watching his favorite television cartoon
throughout the scan, remains motionless thereby avoiding the need for
anesthesia which currently is required for scanning the vast majority of
children under the age of seven when they are scanned in a conventional
lie-down MRI.”

Matters concerning holders of FONAR Corporation stock certificates

Recently, many of our shareholders have received letters from CST (Computer
Share Trust), www.computershare.com, telephone 800-962-4284. It is very
important for investors to respond to these letters or else risk of being
subject to state escheatment laws. Essentially, shareholders holding
older, pre-reverse stock-split certificates must exchange their old
certificates for new ones.

In addition, investors may have changed addresses or appeared to have
abandoned their stock. If this could possibly be you, we urge you to
contact CST to update your information.

Again please call CST at 800-962-4284. For more information on FONAR stock
please visit: www.fonar.com/invest_faq.htm

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR
Scanning™, Full Range of Motion™, pMRI™, Dynamic™,
Multi-Position™, True Flow™, The Proof is in the Picture™,
Spondylography™ Spondylometry™ and Upright Radiology™ are
trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that
may or may not materialize. Additional information on factors that could
potentially affect the company’s financial results may be found in the
company’s filings with the Securities and Exchange Commission.

                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                                ASSETS
                                ------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Current Assets:
  Cash and cash equivalents                     $  1,299,493  $  1,225,619
  Marketable securities                               27,613        22,652
  Accounts receivable - net of allowances for
   Doubtful accounts of $2,289,049 and
   $2,393,326 at June 30, 2010 and 2009,
   respectively                                    4,820,541     5,391,822
  Medical receivables - net of allowances for
   Doubtful accounts of $1,622,000 and
   $1,343,500 at June 30, 2010 and 2009,
   respectively                                       25,225       374,225
  Management fee receivable - net of allowances
   for Doubtful accounts of $5,808,345 and
   $5,093,345 at June 30, 2010 and 2009,
   respectively                                    2,568,526     3,273,756
  Management fee receivable - related medical
   Practices - net of allowances for doubtful
   Accounts of $1,129,818 and $1,094,818 at
   June 30, 2010 and 2009, respectively            1,921,983     2,196,580
  Costs and estimated earnings in excess of          
   billings on uncompleted contracts                 277,384     1,475,706
  Inventories                                      2,826,211     3,172,397
  Current portion of advances and notes to
   related medical practices                          83,423       164,611
  Current portion of note receivable - net of
   allowances for doubtful accounts of $115,000
   and $65,000 at June 30, 2010 and at
   June 30, 2009, respectively                       271,796       517,934
  Prepaid expenses and other current assets          552,800       472,397
                                                 -----------   -----------
      Total Current Assets                        14,674,995    18,287,699

Property and Equipment - Net                       2,108,556     2,892,380

Advances and Notes to Related Medical Practices -
 net of allowances for doubtful accounts of
 $264,791 at June 30, 2010 and at June 30, 2009        -            89,032

Notes Receivable                                       -         1,778,626

Other Intangible Assets - Net                      4,291,419     4,920,241

Other Assets                                         553,875       391,237
                                                ------------  ------------
      Total Assets                              $ 21,628,845  $ 28,359,215
                                                ============  ============


                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                              LIABILITIES
                              -----------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Current Liabilities:
  Current portion of long-term debt and capital
   Leases                                       $    579,436  $    277,494
  Current portion of long-term debt - related
   party                                              87,835        79,509
  Accounts payable                                 3,191,960     3,518,609
  Other current liabilities                        8,065,069     8,460,042
  Unearned revenue on service contracts            5,219,547     5,526,006
  Customer advances                                4,813,327     9,237,921
  Billings in excess of costs and estimated
   earnings on uncompleted contracts               2,743,398     2,026,441

                                                ------------  ------------
      Total Current Liabilities                   24,700,572    29,126,022
                                                ------------  ------------
Long-Term Liabilities:
  Accounts payable                                    62,622       184,168
  Due to related medical practices                   527,891       643,135
  Long-term debt and capital leases, less
   current portion                                 1,566,622       759,211
  Long-term debt, less current portion -
   related party                                      72,341       160,176
  Other liabilities                                  474,763       427,365
                                                ------------  ------------
      Total Long-Term Liabilities                  2,704,239     2,174,055
                                                ------------  ------------
      Total Liabilities                           27,404,811    31,300,077
                                                ------------  ------------
Commitments, Contingencies and Other Matters


                  FONAR CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEETS

                       STOCKHOLDERS' DEFICIENCY
                       ------------------------


                                                         June 30,
                                                --------------------------
                                                    2010          2009
                                                ------------  ------------
Stockholders' Deficiency:
  Class A non-voting preferred stock - $.0001
   par value; authorized - 1,600,000 shares;
   issued and outstanding - 313,451 shares
   at June 30, 2010 and 2009                    $         31  $         31
  Preferred stock - $.001 par value;
   authorized - 2,000,000 shares; issued
   and outstanding - none                               -             -
  Common stock - $.0001 par value; authorized -
   30,000,000 shares at June 30, 2010 and 2009,
   respectively; issued - 4,985,850 and
   4,917,918 shares at June 30, 2010 and 2009,
   respectively; outstanding - 4,974,207 and
   4,906,275 shares at June 30, 2010 and 2009,
   respectively                                          497           491
  Class B common stock (10 votes per share) -
   $.0001 par value; authorized - 800,000
   shares; issued and outstanding - 158 shares
   at June 30, 2010 and 2009                            -             -
  Class C common stock (25 votes per share) -
   $.0001 par value; authorized - 2,000,000
   shares; issued and outstanding - 382,513
   shares at June 30, 2010 and 2009                       38            38
  Paid-in capital in excess of par value         172,379,863   172,280,600
  Accumulated other comprehensive loss               (18,489)      (20,995)
  Accumulated deficit                           (177,271,349) (174,258,607)
  Notes receivable from employee stockholders       (191,167)     (267,030)
  Treasury stock, at cost - 11,643 shares
   of common stock at June 30, 2010 and 2009        (675,390)     (675,390)
                                                ------------  ------------
      Total Stockholders' Deficiency              (5,775,966)   (2,940,862)
                                                ------------  ------------
      Total Liabilities and Stockholders'
        Deficiency                              $ 21,628,845  $ 28,359,215
                                                ============  ============


                  FONAR CORPORATION AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF OPERATIONS

                                               For the Years Ended June 30,
                                               ---------------------------
                                                   2010           2009
                                               ------------   ------------
Revenues
  Product sales - net                          $  9,056,307   $ 17,175,417
  Service and repair fees - net                  10,864,927     10,345,091
  Service and repair fees - related parties -
   net                                              220,000        192,500
  Management and other fees                       7,302,216      7,342,614
  Management and other fees - related
   medical practices - net                        3,786,612      2,911,318
  License fees and royalties                        585,493      1,755,493
                                               ------------   ------------
      Total Revenues - Net                       31,815,555     39,722,433
                                               ------------   ------------
Costs and Expenses
  Costs related to product sales                  7,248,756     10,758,201
  Costs related to service and repair fees        3,026,598      3,992,557
  Costs related to service and repair fees
   - related parties                                 61,284         74,293
  Costs related to management and other fees      5,320,756      4,507,587
  Costs related to management and other fees
   - related medical practices                    2,962,826      2,790,745
  Research and development                        2,458,342      3,593,470
  Selling, general and administrative,
   inclusive of compensatory element of stock
   issuances of $99,269 and $4,061 for the
   years ended June 30, 2010 and 2009,
   respectively                                  11,939,223     13,423,066
  Provision for bad debts                         1,378,500      1,286,451
                                               ------------   ------------
      Total Costs and Expenses                   34,396,285     40,426,370
                                               ------------   ------------
      Loss from Operations                       (2,580,730)      (703,937)

Other Income and (Expenses):
  Interest expense                                 (313,416)      (333,229)
  Interest expense - related parties                (74,486)         -
  Investment income                                 249,290        325,688
  Interest income - related parties                  10,926         20,818
  Other income - net                                 45,674        399,662
  Loss on note receivable                          (350,000)         -
  Gain on sale of consolidated subsidiary             -          1,448,196
                                               ------------   ------------
      (Loss) Income Before Provision For
       Income Taxes                              (3,012,742)     1,157,198

Provision for Income Taxes                            -             35,931
                                               ------------   ------------
       Net (Loss) Income                       $ (3,012,742)  $  1,121,267
                                               ============   ============

SAN DIEGO, CA–(Marketwire – October 13, 2010) –  SpectraScience, Inc. (OTCBB: SCIE), a San Diego based medical device company, today announced that Jim Hitchin, the Company’s current Chairman and CEO, resigned as Chairman effective October 8, 2010 and that the Board elected Mark McWilliams to assume the duties of Chairman of the Board of Directors.

Jim Hitchin, SpectraScience’s CEO, said, “The Company is planning its future growth strategy and as a part of best practices and good governance is separating the Chairmanship from the Chief Executive Officer role consistent with Sarbanes-Oxley guidance.”

Mr. McWilliams has served as a Director of the Company since 2004 and brings his expertise in managing and growing technology companies, a strong network of contacts in the medical device industry and experience in technology transactions. Mr. McWilliams also serves as the CEO of Medipacs, Inc., a development stage infusion pump company. Prior to that, from December 2003 to November 2005, he was Director of Cell Imaging and Analysis at Beckman Coulter after the sale of Q3DM to Beckman in December 2003. He was President and Chief Executive Officer and Director of Q3DM, from October 2001 to December 2003, a life-sciences startup that raised several angel and venture capital funding rounds that was acquired by Beckman Coulter. Previously, he was founder and COO of Medication Delivery Devices (“MDD”), an alternate care infusion systems company that was acquired by Baxter Healthcare in 1996. Mr. McWilliams served as a VP of Research and Development at Baxter Healthcare for three years following the sale of MDD. Prior to MDD, he served as Product Development Manager at the founding of Block Medical where he was responsible for bringing the company’s first two FDA approved products rapidly to market. Block was sold to Hillenbrand Industries in 1991. He previously worked for Hughes Aircraft, Vacuum General and Martin Marietta. Mr. McWilliams has expertise in managing and growing small technology companies and has a strong network of contacts within the medical devices industry. He earned his MSME from the Massachusetts Institute of Technology, his BSME from Northeastern University and holds eight utility patents.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience’s actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience’s other reports filed with the Securities and Exchange Commission (“SEC”) that attempt to advise interested parties of the risks and factors that may affect SpectraScience’s business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company’s LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.

HILO, HI–(Marketwire – October 13, 2010) –   Pacific Quest recently held an informational and educational gathering for visiting educational consultants on the Big Island of Hawaii. Educational consultants arrived from the Midwest, East and West Coast, and Southern U.S. to learn about Pacific Quest’s wilderness therapy programs for struggling youth and young adults. Guests were greeted in camp with a welcoming ceremony, drumming circle, and a nutritious lunch prepared by Pacific Quest students. Afterwards, a garden tour of the four organic farms captured the key components and stages of the program for the consultants.

The next morning, Pacific Quest therapists and wellness staff delivered interactive presentations about the wilderness therapy program. Following the educational presentations, the group spent an afternoon engaging on the gardens and with students in the various phases of the wilderness program. Staff and guests put on work gloves and joined students in working in the nursery, transplanting plants, and harvesting mangoes and papayas on the farm. Students shared their experiences and knowledge of the farm with the visitors and were active teachers for the day.

What came from this gathering was an exchange of knowledge between educational consultants and the students and staff at Pacific Quest. Guests were able to experience the students’ daily life and engage in learning about the mind-body-emotion connection. By hosting this event, Pacific Quest was able to share its sustainable growth model through experiential education, informational sessions, and one-on-one interaction with students and staff.

For more information regarding Pacific Quest, please visit www.pacificquest.org or contact Mark Agosto, Outreach Director, at (808) 937-5806 or via email at [email protected]. Read more at: http://www.pacificquest.org/news/3/196/Pacific-Quest-Wilderness-Therapy-Program-Celebrates-First-Annual-Educational-Consultant-Gathering/.

About Pacific Quest:

Pacific Quest is an outdoor behavioral healthcare (“wilderness therapy”) and sustainable treatment program for struggling teens and young adults, located on the Big Island of Hawaii. Their wilderness programs offer a clinical, yet holistic approach to treatment, going beyond traditional therapy and teaching sustainable life skills. Owned and operated by a veteran team of professionals with over 200 years of combined program experience, Pacific Quest offers a unique approach to treatment that is individualized for each student. Through experiential education, clinical services, a dedicated approach to health and wellness, and sustainable gardening, Pacific Quest provides a structured yet flexible outdoor therapy environment that serves the individual needs of each student.

Click here to see all recent news from this company

LEBANON, OR–(Marketwire – October 13, 2010) –  The College of Osteopathic Medicine of the Pacific-Northwest campus has yet to open its doors in Lebanon, Ore., but prospective students are lining up to apply for the 100 slots available in the inaugural class that begins in fall 2011.

More than 1,400 applications have been received, with several months left in the application process. The interview process began on Oct. 9 and applications will be accepted until Feb. 1, 2011.

“The early deluge of applications only codifies our historic belief that there was a significant unmet need both for medical education and health care services in geographic locations outside the major metropolitan areas of Seattle and Portland,” said COMP Dean Clinton Adams, DO.

Thirty-nine applicants, mostly from the northwest region, traveled to Lebanon for their formal interview with the school on Oct. 9. The interview is the final step in the application process to medical school following the primary and secondary written application documents.

The interviews were conducted by leaders who have volunteered to provide support for COMP-Northwest, including state and regional osteopathic physicians, Oregon business leaders, and representatives from Samaritan Health Services. The volunteers were divided into groups of three and conducted interviews for three to four applicants.

The interview day began with opening remarks by Dean Adams, followed by remarks from Paula Crone, DO, Executive Associate Dean for COMP-Northwest. The interviewees then received an orientation and overview of COMP, including presentations from Admissions, Financial Aid, Student Affairs and the COMP curriculum.

The day concluded with a 90-minute bus tour of the area, taking in the cities of Lebanon, Albany and Corvallis and highlighting the history, geography, amenities, activities and hospital facilities in each city.

“It’s very difficult for Oregonians and students from the Northwest to access medical education in the Northwest,” Adams said. “These students coming from the Northwest, educated in the Northwest, offer a significant solution to the health care needs of the Northwest as we face the ever-increasing demand for primary care and specialty services. The creation of a new opportunity for medical education in a small-town, rural environment will go a long way toward achieving our objective of providing health care to the many underserved areas of the Northwest.”

COMP-Northwest will be the first new medical school built in Oregon in more than a century.
The new COMP-Northwest facility is a 54,000-square-foot building due to be completed in spring 2011. The building contains two large lecture halls and four 60-seat classroom spaces, 15 student breakout and study rooms, an anatomy lab, an osteopathic manual medicine lab and significant research space.

COMP-Northwest is the approved new campus in the expansion of the College of Osteopathic Medicine of the Pacific, which was founded in Pomona, Calif. in 1977. COMP is now one of nine colleges that make up Western University of Health Sciences.

MENOMONEE FALLS, WI–(Marketwire – October 13, 2010) –  Assisted Living Concepts, Inc. (NYSE: ALC) announced that it plans to release its 2010 third quarter financial results before the New York Stock Exchange opens on Tuesday, November 2, 2010. The release will be posted on ALC’s website at www.alcco.com. ALC has scheduled a conference call on Tuesday, November 2, 2010 at 10:00 a.m. (EDT) to discuss its financial results for the third quarter. The toll-free number for the live call is (800) 230-1096 or international (612) 332-0335. A taped rebroadcast of the conference call will be available approximately three hours following the live call until midnight on December 2, 2010, by dialing toll free (800) 475-6701 or international (320) 365-3844 and using access code 174903.

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,305 units in 20 states in the United States. ALC’s residences typically consist of 35 to 60 units and offer residents a supportive, home-like setting and assistance with activities of daily living. ALC employs approximately 4,100 people.

PLANTATION, FL–(Marketwire – October 13, 2010) – For the second year in a row, DentalPlans.com, the top online source for affordable and easy-to-use alternatives to dental insurance, is proud to donate a portion of the firm’s October proceeds to support breast cancer research and awareness. DentalPlans.com is pleased to reaffirm their commitment to women’s health and fund groundbreaking research, education, screening and treatment during National Breast Cancer Awareness Month. 

“As a leader in discount dental plans, our company is fully committed to the well being of our nation’s oral health,” said Buddy Johnson, CEO of DentalPlans.com, Inc. “We are proud to extend our support to raise public awareness and fund life-saving research to ultimately cure this devastating disease.”

In further support of the company’s campaign, DentalPlans.com has provided select network dentists and their staff members with pink dental scrubs and badges inscribed with a pink ribbon and the word ‘hope.’ “Any small thing we can do to eradicate this disease is a huge step forward,” said Dr. Peter Krimsky, who is proudly setting aside the conventional blue scrubs to wear pink ones along with his staff. “We’re raising awareness and prompting our patients to think.”

Dr. Krimsky’s office sees wearing pink as making a difference, one that will one day contribute to the end of the disease. Others are adopting the same thinking and pink is popping up where one might least expect. This year, the National Football League has teamed with the American Cancer Society to feature players, coaches and referees wearing pink apparel in the name of awareness. 

According to the American Cancer Society, breast cancer is the second leading cause of cancer death in women, after lung cancer. One out of eight American women who live to be 85 years of age will develop breast cancer, a risk that was one out of 14 in 1960. Excluding cancers of the skin, breast cancer is the most common cancer diagnosed among U.S. women, accounting for more than 1 in 4 cancers.

Interviews with DentalPlans.com representatives, members and network dentists are available. For more information about DentalPlans.com and editorial inquiries, please contact Shamin Abas or Elizabeth Rose of Shamin Abas Public Relations at 561.366.1226, [email protected] or [email protected]. 

About DentalPlans.com (www.DentalPlans.com)
DentalPlans.com is dedicated to improving oral health nationwide by making quality dental care affordable and accessible to everyone. DentalPlans.com proudly offers the freedom to choose from an extensive selection of discount dental plans designed to save members money on their dental care needs. With more than 40 years of experience in the dental industry, their devoted team quickly transformed DentalPlans.com into a trusted industry leader and the largest online provider of discount dental plans. Since 1999, DentalPlans.com has offered great value and convenience with an extensive choice of money-saving discount dental plans in one user-friendly website.

Click here to see all recent news from this company

TORONTO, ONTARIO–(Marketwire – Oct. 13, 2010) – Unison Health and Community Services is celebrating its official launch on Thursday, October 14^th, from 4 p.m. to 7 p.m., at its Lawrence Heights site located at 12 Flemington Road in Toronto. 

The entire community is invited to learn about Unison Health and Community Services and enjoy entertainment by local performers. There will also be children’s activities and contests, music and dancing, and refreshments.

In August, Unison Health and Community Services received its formal incorporation approval from Ministry of Government Services. This is the first voluntary merger of two community health centres in Ontario – the amalgamation of New Heights Community Health Centres and York Community Services.

Unison builds on the strengths and best practices of both organizations, aiming to improve access to programs and services for clients and community members. The optimal use of resources of both organizations will enhance the delivery of services in a more efficient and cost-effective manner. In collaboration with partners, the integrated services will provide seamless and comprehensive care to clients.

With extended hours at four full-service locations, clients now can have greater access to a wider variety of services. Unison now serves over 22,000 clients and offers core services that include primary health care, counselling, health promotion, early years programs, legal services, harm reduction programs, housing assistance and adult protective services; special programs like Pathways to Education, Diabetes Education and Prevention, and Aging at Home; and a range of community programs targeted to marginalized groups.

For event information, visit www.unisonhcs.org, or call 416-587-8225 or email [email protected].

BIRMINGHAM, UNITED KINGDOM–(Marketwire – Oct. 13, 2010) – A new study has revealed that the UK is a nation of over eaters and grazers with seven out of 10 people reaching for a snack on a regular basis.

The study, showed that half of Britons graze on food when they are bored whilst 23 per cent eat and snack more at times of crisis, turning to food to help them with their emotional needs.

Out of the 3000 people surveyed it was discovered that twice as many women as men snacked when they were stressed with only one in 10 reaching for a tasty treat when they were actually hungry.

Boredom was one of the key roles in overeating with 57 per cent of women scoffing down chocolaty treats and fatty delights and 40 per cent of men doing the same when they were fed up.

Other interesting reasons behind some of the UK’s snacking habits included eating at times of sadness as a way for people to cheer themselves up.

Those who are worried about being overweight should book a consultation with an expert bariatric surgeon at The Hospital Group.

The Hospital Group is the UK’s biggest provider of weight loss surgery, including gastric bands, gastric bypasses and gastric balloons.

David Ross, Chief Executive of The Hospital Group, said: “We are all guilty of having a snack every now and then especially when so many of us lead hectic lifestyles, a quick snack or readymade item can seem like the perfect choice to keep us going.

“However, it’s when people start to graze on a regular basis that it can be bad for their health. Eating sugary and fatty foods throughout the day can lead to weight gain and means that the body isn’t getting the vitamins or nutritional content that it needs.

“Those who are overweight often find themselves in a vicious circle, they want to lose weight and become more healthy but are locked in a battle with overeating and don’t know how to change their bad and harmful eating habits.

“Our consultants ensure that, as well as having an absolute need for a gastric procedure, the patient understands that weight loss surgery isn’t a miracle cure and they would need to work with the band to achieve the healthier lifestyle they desire.”

Since The Hospital Group was established in 1992, it has risen to become the UK’s biggest weight loss surgery providers, performing more gastric procedures last year than the NHS.

The Hospital Group is committed to providing the very highest standards and all procedures are performed by an expert medical team in state-of-the-art facilities that are second to none.

For further information of The Hospital Group’s range of weight-loss procedures, surgery-seekers should visit the website www.thehospitalgroup.org or call our patient care coordinators on 0845 762 6727.

SAN DIEGO, CA–(Marketwire – October 12, 2010) –  When San Diego resident Paul Henderson was hospitalized last year after a fall and subsequent hip surgery, he realized that even highly trained hospital staff were unable to meet his basic comfort needs — not because of lack of concern, but because as an Amyotrophic Lateral Sclerosis (ALS — more commonly known as Lou Gehrig’s disease) patient, he had lost the ability to speak. 

His week in the hospital ICU followed by two weeks at a rehab facility so impacted Henderson and his family — who had to be present at all times to interpret simple messages such as “I need my pain medication,” or “I need to go to the bathroom,” — that it inspired him to set up a new business designed to help anyone with limited speech ability in a care-giving situation.

Called “HelpMeSpeak, Inc.” (www.helpmespeakcards.com), the new company manufactures and sells reasonably priced message cards that can be used virtually anywhere — in hospitals, nursing facilities, rehab facilities or at home. The two-sided cards come in sets of 15, and have basic “needs” phrases in English and Spanish. They are ideally suited to individuals who have suffered strokes, paralysis, or who have other nerve/muscular-damaging diseases (such as ALS or muscular sclerosis). Henderson plans to donate $1 from every sale to the San Diego ALS Association. 

“I assumed that nursing staff would understand that ALS does not impact my mental capacity, only my ability to move and speak. I also assumed that they would be able to interpret my efforts to communicate, or to at least anticipate my basic needs,” said Henderson. “Unfortunately, I was wrong on all counts. They would talk to me as though as I was mentally impaired, and unfortunately, could not understand my efforts to communicate.

“As a result, I would lay cold in the bed for hours, or in pain, all because they couldn’t understand me.”

Henderson’s idea for HelpMeSpeak cards was so simple, he was sure a product like this must already exist. However, after contacting several hospitals and facilities, none were in use. Any communication products he found were not directed to basic patient care and cumbersome to use. 

The HelpMeSpeak cards are held by a ring that can be attached by a clip to a hospital gown or by a lanyard to a bedrail (or for patients not at risk of tangling, around the neck). The cards are color coded — red for English and black for Spanish. The cards are large enough that even if someone has limited hand mobility, it’s possible to handle them with relative ease. For patients without mobility, the caregiver can show the cards — thumbing through until the patient nods that his or her message has been selected.

HelpMeSpeak messages include: “I need my medications,” “Turn off the light,” “I am hot,” “I am cold,” “I am thirsty,” “I need to go to the toilet,” “I am hungry,” “I am OK,” etc. 

HelpMeSpeak cards can be ordered through the company website, www.helpmespeakcards.com, with individual set prices starting at $25 and per-unit Henderson plans to have a customization option introduced soon that will allow users/orders to expand the sets, or change the sets, with other messages as well.

About HelpMeSpeak
HelpMeSpeak, Inc., a San Diego-based company, is the creator and distributor of HelpMeSpeak cards, which are care cards designed by Paul Henderson, an ALS patient, to assist speech-impaired patients with communicating urgent needs to doctors, nurses and other caregivers. Each set of HelpMeSpeak cards contains 15 cards with messages translated in both English and Spanish. For more information, visit www.helpmespeakcards.com.

MENOMONEE FALLS, WI–(Marketwire – October 12, 2010) –  Assisted Living Concepts, Inc. (“ALC”) (NYSE: ALC) announced today that it entered into an agreement to acquire nine senior living residences from HCP, Inc. (NYSE: HCP). The nine residences are currently leased and operated by ALC under leases expiring between 2010 and 2012. The transaction, which is subject to customary closing conditions, is expected to close on or around October 31, 2010. The purchase price is $27.5 million plus certain transaction costs. The nine residences, two of which are located in New Jersey and seven in Texas, contain a total of 365 units. Occupancy of the nine residences is currently 60.0%. Upon completion of this transaction we expect pre-tax cash flow to improve by approximately $1.0 million because of the differential between current lease payments and expected future interest expense. After accounting for taxes we expect cash flow per share to improve by approximately $0.05 per share.

“We are pleased to have reached agreement with HCP to purchase these properties,” commented Laurie Bebo, President and Chief Executive Officer of Assisted Living Concepts, Inc. “In addition to upside opportunities in the existing portfolio, the better performing properties have excess land that may provide good expansion opportunities in the future. After this transaction is completed we will own 161 of our properties or 76% of our total residences.”

Non-GAAP Financial Measures
Cash Flow per Share

Cash flow is defined as cash provided by operating activities. Cash flow per share is defined as cash flow divided by the weighted average diluted common shares outstanding for a fiscal period. Cash flow per share is not a measure of performance under accounting principles generally accepted in the United States of America, or GAAP. We use cash flow per share as a performance indicator.

We understand that cash flow per share may be used by financial analysts and investors as a performance measure in evaluating a company’s ability to service debt and meet other payment obligations or as a common valuation measurement in the long-term care industry. We believe cash flow per share provides meaningful supplemental information because this measure excludes the effects of non-operating factors related to our capital assets, such as depreciation and amortization related to the assets.

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,305 units in 20 states. ALC’s senior living facilities typically consist of 40 to 60 units and offer residents a supportive, home-like setting and assistance with the activities of daily living. ALC employs approximately 4,100 people.

Forward-looking Statements

Statements contained in this release other than statements of historical fact, including statements regarding anticipated financial performance, business strategy and management’s plans and objectives for future operations, including management’s expectations about improving occupancy and private pay mix, are forward-looking statements. Forward-looking statements generally include words such as “expect,” “project,” “point toward,” “intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,” “strategy” or “objective.” Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. In addition to the risks and uncertainties referred to in the release, other risks and uncertainties are contained in ALC’s filings with United States Securities and Exchange Commission and include, but are not limited to, the following: changes in the health care industry in general and the senior housing industry in particular because of governmental and economic influences; changes in general economic conditions, including changes in housing markets, unemployment rates and the availability of credit at reasonable rates; changes in regulations governing the industry and ALC’s compliance with such regulations; changes in government funding levels for health care services; resident care litigation, including exposure for punitive damage claims and increased insurance costs, and other claims asserted against ALC; ALC’s ability to maintain and increase census levels; ALC’s ability to attract and retain qualified personnel; the availability and terms of capital to fund acquisitions and ALC’s capital expenditures; changes in competition; and demographic changes. Given these risks and uncertainties, readers are cautioned not to place undue reliance on ALC’s forward-looking statements. All forward-looking statements contained in this report are necessarily estimates reflecting the best judgment of the party making such statements based upon current information. ALC assumes no obligation to update any forward-looking statement.

Supplementary Financial Information  The following table is limited to financial information for the nine leased residents described above (in thousands, except per share number)

 

BENSALEM, PA–(Marketwire – October 12, 2010) – Healthcare Services Group, Inc. (NASDAQ: HCSG)
reported that revenues for the three months ended September 30, 2010
increased over 9% to $195,114,000 compared to $178,829,000 for the same
2009 period. Net income for the three months ended September 30, 2010
increased approximately 12% to $9,169,000 or $.21 per basic and per diluted
common share, compared to the 2009 third quarter net income of $8,225,000
or $.19 per basic and per diluted common share.

Revenues for the nine months ended September 30, 2010 increased over 12% to
$571,868,000 compared to $510,134,000 for the same 2009 period. Net income
for the nine months ended September 30, 2010 increased approximately 7% to
$25,318,000 or $.58 per basic and $.57 per diluted common share compared to
the 2009 nine month period net income of $23,776,000 or $.55 per basic and
$.54 per diluted common share.

The Board of Directors has declared a third quarter 2010 regular quarterly
cash dividend of $.2325 per common share, payable on November 5, 2010 to
shareholders of record at the close of business October 22, 2010. This
represents an increase over the dividend declared for the 2010 second
quarter, as well as an increase of 16% over the 2009 same period payment.
It is the 30th consecutive regular quarterly cash dividend payment, as well
as the 29th consecutive increase since our initiation of regular quarterly
cash dividend payments in 2003.

Additionally, our Board of Directors has declared a three-for-two stock
split in the form of a 50% stock dividend payable on November 12, 2010 to
holders of record of its Common Stock at the close of business November 8,
2010. All fractional share interests will be rounded up to the nearest
whole number. The effect of this action will be to increase Common Shares
outstanding by approximately 22,000,000 shares.

The Company will host a conference call on October 13, 2010 at 8:30 AM
Eastern Time to discuss its results for the three and nine month periods
ended September 30, 2010. The call in numbers are 888-259-8552 and
913-312-1406 (passcode # 8945410).

Cautionary Statement Regarding Forward-Looking Statements

This release and any schedules incorporated by reference into this report
may contain forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934 (the “Exchange Act”), as amended, which are not
historical facts but rather are based on current expectations, estimates
and projections about our business and industry, our beliefs and
assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,”
“will,” “goal,” and similar expressions are intended to identify
forward-looking statements. The inclusion of forward-looking statements
should not be regarded as a representation by us that any of our plans will
be achieved. We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise. Such forward-looking information is also subject to
various risks and uncertainties. Such risks and uncertainties include, but
are not limited to, risks arising from our providing services exclusively
to the health care industry, primarily providers of long-term care; credit
and collection risks associated with this industry; one client accounting
for approximately 11% of revenues in the nine month period ended September
30, 2010; risks associated with our acquisition of Contract Environmental
Services, Inc., including integration risks or costs, or such business not
achieving expected financial results or synergies or failure to otherwise
perform as expected; our claims experience related to workers’ compensation
and general liability insurance; the effects of changes in, or
interpretations of laws and regulations governing the industry, our
workforce and services provided, including state and local regulations
pertaining to the taxability of our services; and the risk factors
described in our Form 10-K filed with the Securities and Exchange
Commission for the year ended December 31, 2009 in Part I thereof under
“Government Regulation of Clients,” “Competition” and “Service
Agreements/Collections,” and under Item IA “Risk Factors.” Many of our
clients’ revenues are highly contingent on Medicare and Medicaid
reimbursement funding rates, which Congress has affected through the
enactment of a number of major laws during the past decade, most recently
the March 2010 enactment of the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010. Currently,
the U.S. Congress is considering further changes or revising legislation
relating to health care in the United States which, among other
initiatives, may impose cost containment measures impacting our clients.
These laws and proposed laws and forthcoming regulations have significantly
altered, or threaten to alter, overall government reimbursement funding
rates and mechanisms. The overall effect of these laws and trends in the
long-term care industry have affected and could adversely affect the
liquidity of our clients, resulting in their inability to make payments to
us on agreed upon payment terms. These factors, in addition to delays in
payments from clients, have resulted in, and could continue to result in,
significant additional bad debts in the near future. Additionally, our
operating results would be adversely affected if unexpected increases in
the costs of labor and labor related costs, materials, supplies and
equipment used in performing services could not be passed on to our
clients.

In addition, we believe that to improve our financial performance we must
continue to obtain service agreements with new clients, provide new
services to existing clients, achieve modest price increases on current
service agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels. Furthermore, we
believe that our ability to sustain the internal development of managerial
personnel is an important factor impacting future operating results and
successfully executing projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of
professional housekeeping, laundry and dietary services to long-term care
and related facilities.

                      HEALTHCARE SERVICES GROUP, INC.
                          CONDENSED CONSOLIDATED
                           STATEMENTS OF INCOME
                                (Unaudited)


                                                For the Three Months Ended
                                                        September 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 195,114,000 $ 178,829,000
Operating costs and expenses:
   Cost of services provided                      168,384,000   155,228,000
   Selling, general and administrative             14,488,000    11,936,000
                                                ------------- -------------
Income from operations                             12,242,000    11,665,000
Other income:
    Investment and interest income                  1,182,000     1,709,000
                                                ------------- -------------
Income before income taxes                         13,424,000    13,374,000
Income taxes                                        4,255,000     5,149,000
                                                ------------- -------------
Net income                                      $   9,169,000 $   8,225,000
                                                ============= =============

Basic earnings per common share                 $         .21 $         .19
                                                ============= =============

Diluted earnings per common share               $         .21 $         .19
                                                ============= =============

Cash dividends per common share                 $         .23 $         .19
                                                ============= =============
Basic weighted average number of
 common shares outstanding                         44,026,000    43,626,000
                                                ============= =============

Diluted weighted average number of
 common shares outstanding                         44,719,000    44,334,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.
                          CONDENSED CONSOLIDATED
                           STATEMENTS OF INCOME
                                (Unaudited)


                                                 For the Nine Months Ended
                                                       September 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 571,868,000 $ 510,134,000
Operating costs and expenses:
   Cost of services provided                      492,196,000   438,950,000
   Selling, general and administrative             41,539,000    36,328,000
                                                ------------- -------------
Income from operations                             38,133,000    34,856,000
Other income:
    Investment and interest income                  1,549,000     3,803,000
                                                ------------- -------------
Income before income taxes                         39,682,000    38,659,000
Income taxes                                       14,364,000    14,883,000
                                                ------------- -------------
Net income                                      $  25,318,000 $  23,776,000
                                                ============= =============

Basic earnings per common share                 $         .58 $         .55
                                                ============= =============

Diluted earnings per common share               $         .57 $         .54
                                                ============= =============

Cash dividends per common share                 $         .66 $         .54
                                                ============= =============
Basic weighted average number of common shares
 outstanding                                       43,964,000    43,540,000
                                                ============= =============

Diluted weighted average number of common
 shares outstanding                                44,677,000    44,224,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.
                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)


                                                September 30, December 31,
                                                    2010          2009
                                                ------------- -------------
Cash and cash equivalents                       $  26,109,000 $  31,301,000
Marketable securities, net                         44,498,000    52,648,000
Accounts receivable, net                          108,363,000   104,356,000
Other current assets                               24,350,000    23,865,000
                                                ------------- -------------
  Total current assets                            203,320,000   212,170,000

Property and equipment, net                         5,591,000     4,391,000
Notes receivable- long term, net                    6,084,000     4,623,000
Goodwill, net                                      16,955,000    17,087,000
Other Intangible Assets, net                        7,730,000     8,862,000
Deferred compensation funding                      12,510,000    10,783,000
Other assets                                       10,082,000     7,976,000
                                                ------------- -------------

Total Assets                                    $ 262,272,000 $ 265,892,000
                                                ============= =============


Accrued insurance claims- current               $   6,032,000 $   4,844,000
Other current liabilities                          18,186,000    29,873,000
                                                ------------- -------------
  Total current liabilities                        24,218,000    34,717,000

Accrued insurance claims- long term                14,074,000    11,302,000
Deferred compensation liability                    12,837,000    11,099,000
Stockholders' equity                              211,143,000   208,774,000
                                                ------------- -------------

Total Liabilities and Stockholders' Equity      $ 262,272,000 $ 265,892,000
                                                ============= =============